Applied Value Group

Bruce Grant, the founder and chairman, directs the firm's investment strategy alongside CEO Conny Carlsson. The group does not operate an independent investment committee with outside members. Portfolio oversight is integrated with the management consulting practice, meaning senior advisors often participate in both client engagements and investment diligence.

Applied Value Group operates as a single family office, investing permanent capital generated by Bruce Grant's management consultancy. It does not manage third-party funds or have external limited partners. The structure allows the group to hold assets indefinitely without a mandated exit timeline.

The firm primarily executes direct control buyouts and build-ups in operating companies. It has a dedicated venture arm, Applied Value Technologies, which makes earlier-stage minority investments in enterprise software and industrial tech. There is no public record of Applied Value Group acting as a limited partner in external private equity funds.

Proprietary deal flow is a core advantage. The management consultancy retains relationships with large industrial and technology companies worldwide, particularly in Sweden and North America. Corporate carve-outs, family-owned business successions, and distress-driven divestitures identified through consulting mandates form the bulk of the investment pipeline.

Applied Value Group's capital was generated by its founder Bruce Grant through the Applied Value management consultancy, which he launched in 1997. Rather than distributing consulting profits, the firm reinvested them into a portfolio of operating companies. The consultancy continues to provide a recurring source of internal capital for new acquisitions.

Applied Value Group rarely co-invests alongside traditional private equity firms, preferring control positions negotiated bilaterally. On select venture-stage deals through Applied Value Technologies, the firm has partnered with other family offices and corporate venture arms. The group does not market co-investment slots to external allocators.

The firm avoids regulated financial services, speculative biotech, and commodity-extraction industries. Its operational playbook requires businesses where management consulting interventions can materially improve margins — a threshold that screens out sectors dependent on regulatory approvals or resource price fluctuations for returns.